Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

SeaStar Medical - SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LakeShore Biopharma Announces Fiscal Year 2025 Financial Results

New Form SCHEDULE 13G/A - Inventiva S.A. Filed: 2025-07-31 AccNo: 0002005369-25-000010 Size: 16 KB

New Form 8-K - Third Harmonic Bio, Inc. Filed: 2025-07-31 AccNo: 0001193125-25-170428 Size: 193 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 6-K - LakeShore Biopharma Co., Ltd. Filed: 2025-07-31 AccNo: 0001213900-25-069883 Size: 146 KB

New Form 144 - QUEST DIAGNOSTICS INC Filed: 2025-07-31 AccNo: 0001959173-25-004842 Size: 5 KB

New Form PRE 14A - Mallinckrodt plc Filed: 2025-07-31 AccNo: 0001104659-25-072616 Size: 1 MB

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor "What This Means" Segment

New Form 10-Q - Air Products & Chemicals, Inc. Filed: 2025-07-31 AccNo: 0000002969-25-000044 Size: 14 MB

New Form 4 - CYANOTECH CORP Filed: 2025-07-31 AccNo: 0001437749-25-024127 Size: 6 KB

New Form 4 - CYANOTECH CORP Filed: 2025-07-31 AccNo: 0001437749-25-024125 Size: 8 KB